Euro vs US Dollar

Registrieren Sie sich für Echtzeit-Benachrichtigungen, benutzerdefinierte Portfolios und Marktbewegungen.

Registrieren

LPCN Lipocine Inc

5,32

0,00 (0,00%)

Vor Marktöffnung

Zuletzt aktualisiert: 10:09:19

Verzögert um 15 Minuten

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]

Article too big to display. Click here to view on the SEC website

Lipocine (NASDAQ:LPCN)
Historical Stock Chart
Von Apr 2024 bis Mai 2024

Click Here for more Lipocine Charts.

Lipocine (NASDAQ:LPCN)
Historical Stock Chart
Von Mai 2023 bis Mai 2024

Click Here for more Lipocine Charts.

News Lipocine Inc

Lipocine Announces Financial Results for the First Quarter Ended March 31, 2024
Donnerstag 9 Mai 2024 (4 Tage vor) • PR Newswire (US)

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Donnerstag 9 Mai 2024 (4 Tage vor) • Edgar (US Regulatory)

Form 8-K - Current report
Donnerstag 9 Mai 2024 (4 Tage vor) • Edgar (US Regulatory)

Lipocine Announces Late Breaking Oral Presentation of Data from the Phase 2 Study of LPCN 1148 at EASL Congress 2024
Mittwoch 8 Mai 2024 (5 Tage vor) • PR Newswire (US)

Form 8-K - Current report
Mittwoch 8 Mai 2024 (5 Tage vor) • Edgar (US Regulatory)

Lipocine Announces Completion of Dosing in Pivotal Study of Postpartum Depression Candidate, LPCN 1154
Mittwoch 1 Mai 2024 (2 Wochen vor) • PR Newswire (US)

Lipocine Announces Positive LPCN 2401 Clinical Results Showing Improved Body Composition in Participants with Obesity
Donnerstag 11 April 2024 (1 Monat vor) • PR Newswire (US)

Lipocine Announces Positive Week 52 Results from LPCN 1148 Phase 2 Study in Patients with Cirrhosis
Donnerstag 28 März 2024 (2 Monate vor) • PR Newswire (US)

Lipocine Announces First Cohort Dosed in Pivotal Study of LPCN 1154
Montag 25 März 2024 (2 Monate vor) • PR Newswire (US)

Form 8-K - Current report
Donnerstag 7 März 2024 (2 Monate vor) • Edgar (US Regulatory)

Lipocine Announces Financial Results for the Full Year Ended December 31, 2023
Donnerstag 7 März 2024 (2 Monate vor) • PR Newswire (US)

Form 8-K - Current report
Donnerstag 7 März 2024 (2 Monate vor) • Edgar (US Regulatory)

Weitere Lipocine Inc News-Artikel

Financial Select Sector

Deutsche Lufthansa

JP Morgan Chase

Euro vs US Dollar

Gold vs US Dollar

BNP Paribas (QX)

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen